Rappersberger K et al. |
Clearing of psoriasis by a novel immunosuppressive macrolide. |
1996 |
J. Invest. Dermatol. |
pmid:8618008
|
Panyi G et al. |
Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8619842
|
Kiang D et al. |
Cloning the gene encoding Schistosoma mansoni p50, an immunophilin. |
1996 |
Gene |
pmid:8621074
|
Roth D et al. |
A prospective study of hepatitis C virus infection in renal allograft recipients. |
1996 |
Transplantation |
pmid:8623154
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Pham SM et al. |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience. |
1996 |
Transplant. Proc. |
pmid:8623208
|
Satomura K et al. |
Pharmacokinetics of FK 506 in living-related liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623209
|
Loss M et al. |
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. |
1996 |
Transplant. Proc. |
pmid:8623210
|
Kogi M et al. |
Effects of calyculin A and FK506 on the O2- generation of rat peritoneal macrophages. |
1996 |
Tokai J. Exp. Clin. Med. |
pmid:9239803
|
Sung RS et al. |
Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. |
1996 |
Transplant. Proc. |
pmid:8623427
|
Pirenne J et al. |
Addition of the colon to small bowel grafts causes lethal graft-versus-host disease in FK 506-treated pigs. |
1996 |
Transplant. Proc. |
pmid:8623447
|
Harrison DM et al. |
Reduction in hospital stay after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623451
|
Andrews WS et al. |
Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623452
|
Ketel BL et al. |
Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation. |
1996 |
Transplant. Proc. |
pmid:8623453
|
Kyo M et al. |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin. |
1996 |
Transplant. Proc. |
pmid:8623457
|
D'Silva M et al. |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623467
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Singh N et al. |
Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. |
1996 |
Surgery |
pmid:8644012
|
Morozumi K et al. |
Diagnosis of chronic rejection using peritubular and glomerular capillary lesions. |
1996 |
Transplant. Proc. |
pmid:8644331
|
Colombani PM et al. |
Liver transplantation in infants younger than 1 year of age. |
1996 |
Ann. Surg. |
pmid:8645039
|
Muraoka K et al. |
Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy. |
1996 |
J. Clin. Invest. |
pmid:8647935
|
Buckle GJ et al. |
HTLV-I-induced T-cell activation. |
1996 |
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. |
pmid:8797712
|
Platz KP et al. |
Management of acute steroid-resistant rejection after liver transplantation. |
1996 |
World J Surg |
pmid:8798364
|
Brunke M et al. |
Luciferase assembly after transport into mammalian microsomes involves molecular chaperones and peptidyl-prolyl cis/trans-isomerases. |
1996 |
J. Biol. Chem. |
pmid:8798557
|
Zhang Q et al. |
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8799169
|
Spencer DM et al. |
Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. |
1996 |
Curr. Biol. |
pmid:8805308
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Ichikawa Y et al. |
Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation. |
1996 |
Int. J. Urol. |
pmid:8776613
|
Mugiya S et al. |
Renal blood flow and serotonin metabolism in tacrolimus treated rats. |
1996 |
Int. J. Urol. |
pmid:8776615
|
Nagai H et al. |
The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. |
1996 |
Ann. N. Y. Acad. Sci. |
pmid:8906215
|
Tsunoda SM and Aweeka FT |
The use of therapeutic drug monitoring to optimise immunosuppressive therapy. |
1996 |
Clin Pharmacokinet |
pmid:8906895
|
Yocum DE |
Cyclosporine, FK-506, rapamycin, and other immunomodulators. |
1996 |
Rheum. Dis. Clin. North Am. |
pmid:8907069
|
Lu YF et al. |
FK506, a Ca2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus. |
1996 |
Neurosci. Lett. |
pmid:8907327
|
Ye Q et al. |
Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. |
1996 |
Transplant. Proc. |
pmid:8907895
|
Walgenbach KJ et al. |
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. |
1996 |
Transplant. Proc. |
pmid:8907896
|
Nüssler NC et al. |
CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection. |
1996 |
Transplant. Proc. |
pmid:8907898
|
Wu J et al. |
Reversal of multidrug resistance by tacrolimus hydrate. |
1996 |
Methods Find Exp Clin Pharmacol |
pmid:9121220
|
Perego C et al. |
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907908
|
Alessiani M et al. |
Combined FK 506 and mycophenolate mofetil immunosuppression prolongs survival after small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907922
|
Ankarcrona M et al. |
Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. |
1996 |
FEBS Lett. |
pmid:8830666
|
Alessiani M et al. |
Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs. |
1996 |
Transplantation |
pmid:8830816
|
Woodle ES et al. |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplantation |
pmid:8830821
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Ho S et al. |
The mechanism of action of cyclosporin A and FK506. |
1996 |
Clin. Immunol. Immunopathol. |
pmid:8811062
|
Nishino H et al. |
3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. |
1996 |
J. Chem. Neuroanat. |
pmid:8811425
|
Sonatore LM et al. |
The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. |
1996 |
Anal. Biochem. |
pmid:8811923
|
James DG |
A new immunosuppressant: tacrolimus. |
1996 |
Postgrad Med J |
pmid:8977938
|
Weppler D et al. |
Status of liver and gastrointestinal transplantation at the University of Miami. |
1996 |
Clin Transpl |
pmid:9286568
|
Cooley HM et al. |
Resolution of pyoderma gangrenosum using tacolimus (FK-506) |
1996 |
Aust N Z J Med |
pmid:8744629
|
Golbaekdal K et al. |
The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs. |
1996 |
J. Pharm. Pharmacol. |
pmid:8961168
|
Schumacher G et al. |
Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962200
|
Woodle ES et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplant. Proc. |
pmid:8962225
|
Scott-Douglas N et al. |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy. |
1996 |
Transplant. Proc. |
pmid:8962226
|
Kliem V et al. |
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. |
1996 |
Transplant. Proc. |
pmid:8962227
|
Becker G et al. |
Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8962228
|
Kiuchi T et al. |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects. |
1996 |
Transplant. Proc. |
pmid:8962229
|
Guckelberger O et al. |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? |
1996 |
Transplant. Proc. |
pmid:8962230
|
Hisatomi A et al. |
Effect of Prograf (FK506) on spermatogenesis in rats. |
1996 |
Toxicology |
pmid:8658548
|
Harihara Y et al. |
Effects of interferon alpha/beta on cardiac allografts. |
1996 |
Transplant. Proc. |
pmid:8658645
|
Shinozuka N et al. |
Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8658649
|
Nishimura Y et al. |
Whole organ vascularized thymus allografting effectively modulates cardiac rejection. |
1996 |
Transplant. Proc. |
pmid:8658660
|
Tanabe K et al. |
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658670
|
Sugito K et al. |
A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658683
|
Degawa H et al. |
Blocking of ICAM-1 and LFA-1 in rat liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8658695
|
Taylor P et al. |
Conformational polymorphism in peptidic and nonpeptidic drug molecules. |
1996 |
Biopolymers |
pmid:9101762
|
Soldin SJ |
Receptor assays in the clinical laboratory. |
1996 |
Clin. Biochem. |
pmid:8884064
|
Woodle ES et al. |
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. |
1996 |
Clin Transplant |
pmid:8884103
|
Karashima T et al. |
FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle. |
1996 |
J. Dermatol. Sci. |
pmid:8884530
|
Monfar M and Blenis J |
Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone. |
1996 |
Mol. Endocrinol. |
pmid:8885245
|
Andoh TF et al. |
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. |
1996 |
Kidney Int. |
pmid:8887267
|
Shapiro R et al. |
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. |
1996 |
Transplantation |
pmid:8932264
|
Mysliwiec J et al. |
The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats. |
1996 |
Thromb. Res. |
pmid:8837316
|
Alak AM and Lizak PP |
Quality assurance procedure for monitoring tacrolimus (FK506) concentrations in whole blood by IMx assay. |
1996 |
Ther Drug Monit |
pmid:8738766
|
Ockenfels HM et al. |
Inhibition of T cell cAMP formation by cyclosporin A and FK506. |
1996 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8740144
|
Thompson PA and Mosley CA |
Tacrolimus-phenytoin interaction. |
1996 |
Ann Pharmacother |
pmid:8740340
|
Christophers E |
Psoriasis: mechanisms and entry points for possible therapeutic interventions. |
1996 |
Australas. J. Dermatol. |
pmid:8713012
|
Alak AM and Lizak P |
Stability of FK506 in blood samples. |
1996 |
Ther Drug Monit |
pmid:8721287
|
Büttemeyer R et al. |
Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. |
1996 |
Plast. Reconstr. Surg. |
pmid:8532772
|
Yu C et al. |
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. |
1996 |
Bone Marrow Transplant. |
pmid:8722370
|
Christians U et al. |
Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes. |
1996 |
Br J Clin Pharmacol |
pmid:8866917
|
|
[Tacrolimus--a new perspective in kidney transplantation]. |
1996 |
Urologe A |
pmid:9022401
|
Cox KL and Freese DK |
Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation. |
1996 |
Clin Invest Med |
pmid:8889279
|
Bridges ND et al. |
Lung transplantation in infancy and early childhood. |
1996 |
J. Heart Lung Transplant. |
pmid:8889985
|
Iwasaki K et al. |
Binding of tacrolimus (FK506) with human plasma proteins re-evaluation and effect of mycophenolic acid. |
1996 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:9029671
|
Bousvaros A et al. |
Tacrolimus (FK-506) treatment of fulminant colitis in a child. |
1996 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:8890089
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Timmerman LA et al. |
Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. |
1996 |
Nature |
pmid:8893011
|
Tokunaga Y and Alak AM |
FK506 (tacrolimus) and its immunoreactive metabolites in whole blood of liver transplant patients and subjects with mild hepatic dysfunction. |
1996 |
Pharm. Res. |
pmid:8668663
|
Vincenti F et al. |
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8669100
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Dhar DK et al. |
FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. |
1996 |
J. Surg. Res. |
pmid:8592405
|
Kay JE |
Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. |
1996 |
Biochem. J. |
pmid:8670043
|
Schmaldienst S and Horl WH |
Bacterial infections during immunosuppression - immunosuppressive agents interfere not only with immune response, but also with polymorphonuclear cell function. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8672015
|
Taylor PJ et al. |
Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. |
1996 |
Clin. Chem. |
pmid:8595724
|
Hartley AD et al. |
cAMP inhibits bud growth in a yeast strain compromised for Ca2+ influx into the Golgi. |
1996 |
Mol. Gen. Genet. |
pmid:8709962
|
Tokime T et al. |
Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. |
1996 |
Neurosci. Lett. |
pmid:8710192
|
Dan Y et al. |
IL-3 augments TCR-mediated responses of type 2 CD4 T cells. |
1996 |
J. Immunol. |
pmid:8598473
|
Beretta L et al. |
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. |
1996 |
EMBO J. |
pmid:8599949
|